๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
NCT07122401Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Phase 3
424
Shanghai
2025-09-30
Not yet open
Mechanistic Studies of Chronic COPD Using Single-Cell Sequencing and Single-Cell Spatial Transcriptomics
NCT07208123COPD
Tongji University
Observational
150
Shanghai
2025-09-30
Recruiting
Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma
NCT07589439Asthma
Shanghai Novamab Biopharmaceuticals Co., Ltd.
Phase 2
216
Shanghai
2025-09-30
Recruiting
SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment
NCT07182721HER2-positive, Unresectable, Locally Advanced or Metastatic Breast Cancer, SKB264, Inetetamab
DrugsInetetamab·Sacituzumab tirumotecan
Fudan University
Phase 2
48
Shanghai
2025-09-30
Recruiting
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
NCT07198386NASH
DrugCS060380
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Active, closed
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
NCT07176702Metastatic PDAC, HER2-positive Status
DrugHLX22
Shanghai Zhongshan Hospital
Phase 2
45
Nanjing, Shanghai
2025-09-30
Not yet open
A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy
NCT07175584Hemorrhoidal Disease, Cervical Cancer Radiation Complications
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
300
Shanghai
2025-09-29
Recruiting
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
NCT07187635Bladder Cancer, Liquid Biopsy, Repeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital
Not applicable
196
Nanchang, Guangzhou, Xingtai, Kunming, Shanghai, Tianjin
2025-09-28
Active, closed
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
NCT07283718Breast Cancer Invasive
Wenjin Yin
Observational
2,467
Shanghai
2025-09-28
Recruiting
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
NCT07083154Dementia, Mild, Mild Cognitive Impairment, Type 2 Diabetes
DrugMazdutide
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
420
Changsha, Changzhou, Nanjing, Dalian, Shanghai
2025-09-27
Recruiting
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
NCT07117630Breast Cancer
DrugFulvestrant
Fudan University
Phase 2
60
Shanghai
2025-09-25
Recruiting
Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
NCT07351487TNBC - Triple-Negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
37
Hefei, Shanghai
2025-09-25
Recruiting
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
NCT07180160Advanced Breast Cancer
DrugsIparomlimab and Tuvonralimab·Fulvestrant
Wenjin Yin
Phase 2
123
Shanghai
2025-09-25
Recruiting
A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma
NCT07152405Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
DrugBL-M07D1
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
490
Harbin, Shanghai
2025-09-24
Recruiting
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
NCT07191444Still's Disease, Adult-Onset
DrugsAnakinra·Firsekibart
Ruijin Hospital
Observational
20
Shanghai
2025-09-24
By invitation
HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial
NCT07488546Decompensated Cirrhosis
Shanghai Huicun Medical Technology Co., Ltd.
Phase 1/2
39
Shanghai
2025-09-23
Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
NCT07058519Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
Shanghai Chest Hospital
Phase 2
250
Shanghai
2025-09-23
Active, closed
A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
NCT07186413Acne Vulgaris
Galderma R&D
Phase 3
561
Shanghai
2025-09-23
Recruiting
A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
NCT06953453Cancer
Lee's Pharmaceutical Limited
Phase 1
100
Zhengzhou, Shanghai
2025-09-23
Recruiting
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT07136142Malignant Solid Tumor
DrugFH-006
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
150
Shanghai, Tianjin
2025-09-23
Recruiting
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
NCT07166757Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
90
Shanghai
2025-09-22
Recruiting
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
NCT07357623Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital
Phase 2
96
Hefei, Beijing, Zhengzhou, Shanghai
2025-09-22
Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
NCT07197827Advanced Solid Tumor
DrugsPembrolizumab·Bevacizumab
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
424
Harbin, Shanghai, Hangzhou
2025-09-22
Recruiting
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma๏ผˆSELINA๏ผ‰
NCT07191431Lymphoma Cns
DrugsSelinexor·Orelabrutinib
Ruijin Hospital
Not applicable
25
Shanghai
2025-09-22
Recruiting
Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients
NCT07301970Critical Illness, Pain
DrugRemifentanil
Fudan University
Observational
45
Shanghai
2025-09-22
Recruiting
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
NCT07162012NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
24
Shanghai
2025-09-20
Recruiting
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
NCT07114315Pancreatic Cancer
DrugsAK130·Bevacizumab
Akeso
Phase 2
160
Shanghai, Tianjin
2025-09-19
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
NCT07170800Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
DrugDelamanid
WestVac Biopharma Co., Ltd.
Phase 2
60
Wuhan, Changsha, Nanjing, Jinan, Chengdu, Beijing, Shanghai
2025-09-19
Recruiting
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
NCT07126665Advanced Malignant Solid Tumor
DrugsMHB088C·MHB039A
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
116
Shanghai
2025-09-18
Recruiting
A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
NCT06682780Advanced Solid Tumor
DrugsNiraparib·Lenvatinib·Carboplatin·Paclitaxel
LaNova Medicines Limited
Phase 1/2
320
Shanghai
2025-09-17
Recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578Alzheimers Disease
DrugTrontinemab
Hoffmann-La Roche
Phase 3
800
Xuzhou, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-09-17
Recruiting
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
NCT07215650Generalized Myasthenia Gravis
DrugCizutamig
Candid Therapeutics
Phase 1
44
Fuzhou, Guangzhou, Guiyang, Zhengzhou, Changchun, Shanghai, Taiyuan, Chengdu
2025-09-16
Recruiting
Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations
NCT07134998Advanced KRAS G12D Mutant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
153
Shanghai, Chengdu
2025-09-16
Not yet open
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders
Children's Hospital of Fudan University
Observational
1,000
Hefei, Xiamen, Liuzhou, Harbin, Kunshan, Xi'an, Shanghai, Chengdu
2025-09-15
Recruiting
Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis
NCT07088757Post-ERCP Pancreatitis
Changhai Hospital
Phase 4
1,366
Shanghai, Zhejiang
2025-09-15
Recruiting
Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
NCT07003386Acute Ischemic Stroke AIS
DrugGalantamine
Shanghai Yueyang Integrated Medicine Hospital
Phase 2/3
66
Shanghai
2025-09-15
Not yet open
Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer
NCT07117877Platinum Resistant Ovarian Cancer, Platinum Refractory Epithelial Ovarian Cancer, Ovarian Cancer (OvCa)
Fudan University
Phase 2
33
Shanghai
2025-09-15
Not yet open
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
NCT07156591Gastric Retention
Fudan University
Observational
460
Shanghai
2025-09-15
Not yet open
Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy
NCT07169864Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), Neoadjuvant Therapy
Jinsong Lu
Not applicable
44
Shanghai
2025-09-15
Not yet open
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
NCT07152756Gastric Retention
Fudan University
Observational
418
Shanghai
2025-09-15
Recruiting
SOCIAL_HF: Improving Social Frailty Through Interactive Learning
NCT07234565Heart Failure
The University of Hong Kong
Not applicable
208
Shanghai
2025-09-15
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Luoyang, Macau, Nanchang, Shanghai
2025-09-13
Recruiting
A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications
NCT07142980Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
120
Shanghai
2025-09-12
Recruiting
A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT07003321Solid Tumor
DrugHRS-4508
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
120
Shanghai
2025-09-12
Recruiting
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
NCT07156370Hypercortisolism, Type 2 Diabetes (T2DM)
Shanghai 6th People's Hospital
Observational
500
Shanghai
2025-09-11
Active, closed
Artificial Intelligence for Diagnosing Periodontitis and Monitoring Gingival Inflammation
NCT07629934Periodontal Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
900
Shanghai
2025-09-10
Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
NCT07029828Severe Alopecia Areata
DrugsRitlecitinib higher·Ritlecitinib lower
Pfizer
Phase 3
140
Shanghai
2025-09-10
Not yet open
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
NCT07179939HER2-positive Breast Cancer
DrugsDalpiciclib·Pyrotinib·Trastuzumab Rezetecan·Trastuzumab
Fudan University
Phase 2
288
Shanghai
2025-09-10
Recruiting
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
NCT07272499Mantle Cell Lymphoma (MCL)
DrugsLisaftoclax·Orelabrutinib·Rituximab
Ruijin Hospital
Phase 2
25
Shanghai
2025-09-10
Recruiting
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
NCT07295938Mycobacterium Abscessus Pulmonary Disease
Shanghai University of Traditional Chinese Medicine
Phase 2
352
Beijing, Guangdong, Hefei, Nanchang, Shanghai
2025-09-08
Recruiting
A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
NCT07087158Renal Cell Carcinoma (RCC)
DrugPazopanib
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 2
30
Shanghai
2025-09-08
Recruiting
Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors
NCT07348042Tumor, Solid
Xian-Jun Yu
Phase 1
198
Shanghai
2025-09-07
Active, closed
Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101
NCT07178327Osteoporotic Fracture
Shanghai TTM-Bio Technology Co., Ltd
Phase 1
64
Bengbu, Shanghai
2025-09-06
Recruiting
Study on Carotenoid-Based Instrumental Index
NCT07198503Skin Carotenoid Status
ChinaNorm
Observational
600
Shanghai
2025-09-06
Recruiting
A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
NCT07099430Advanced Melanoma
DrugsLBL-007·LBL-024·Tislelizumab
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
200
Fuzhou, Guangzhou, Nanning, Wuhan, Nanjing, Changchun, Jinan, Shanghai
2025-09-05
Recruiting
SCRT Followed by CAPOX + Bev ยฑ PD-1 Inhibitor for TNT in LARC
NCT07198165Rectal Cancer, Rectal Adenocarcinoma, Rectal Cancer, Radiotherapy, Rectal Cancer Patients
Ruijin Hospital
Phase 2
104
Shanghai
2025-09-05
Recruiting
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
NCT07036991Carotid Artery Stenosis
Changhai Hospital
Observational
406
Shanghai
2025-09-05
Recruiting
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases
NCT07144462Autoimmune
DrugsFludarabine·Cyclophosphamide
Neukio Biotherapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
8
Shanghai
2025-09-04
Recruiting
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
NCT07215663Systemic Lupus Erythematosus (SLE)
DrugCizutamig
Candid Therapeutics
Phase 1
47
Beijing, Guangzhou, Luoyang, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-09-04
Recruiting
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
NCT07194005Gastric Cancer
DrugsTegafur Gimeracil Oteracil·Disitamab Vedotin·Sintilimab·Oxaliplatin
Fudan University
Phase 2
30
Shanghai
2025-09-04
Not yet open
Triple Branched Stent Graft System for Aortic Arch Lesions
NCT07067840Aortic Arch Aneurysm, Aortic Arch Pseudoaneurysm, Aortic Arch Ulcer
Changhai Hospital
Not applicable
96
Shanghai
2025-09-01
Not yet open
Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency
NCT07020429Premature Ovarian Insufficiency
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
276
Shanghai
2025-09-01
Not yet open
Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.
NCT07147088Advanced Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2
36
Shanghai
2025-09-01
By invitation
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147Myopia Progressing
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
144
Shanghai
2025-09-01
Recruiting
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
NCT07395960Mild Cognitive Impairment, Overweight or Obesity, Elderly
Fudan University
Phase 1/2
54
Shanghai
2025-09-01
Not yet open
Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
NCT07135297Lung Cancer (Diagnosis)
Shanghai Chest Hospital
Not applicable
465
Beijing, Zhengzhou, Nanjing, Ningbo, Shanghai
2025-09-01
Recruiting
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
NCT07183280Solid Pseudopapillary Neoplasm of the Pancreas
Fudan University
Observational
2,000
Shanghai
2025-09-01
Recruiting
AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema
NCT07349095Peri-implant Mucositis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
200
Shanghai
2025-09-01
Recruiting
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
NCT07303023Nasopharyngeal Carcinoma (NPC)
Fudan University
Phase 3
462
Shanghai, Hangzhou, Chengdu, Chongqing
2025-09-01
Not yet open
Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesions
NCT07149597Peripheral Pulmonary Lesions (PPLs)
Shanghai Chest Hospital
Observational
50
Shanghai
2025-09-01
Recruiting
High-Resolution CT for Heart
NCT07169201Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
500
Shanghai
2025-09-01
Recruiting
Exploration of the Effectiveness of Vibrational Intervention in Improving Insomnia Symptoms
NCT06983275Chronic Insomnia
Jia Xiu
Not applicable
120
Shanghai
2025-09-01
Recruiting
Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
NCT07147101Advanced Hepatocellular Carcinoma (HCC)
Fudan University
Observational
150
Shanghai
2025-09-01
Recruiting
Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
NCT07389876Gastric Cancer, Second-line Treatment
DrugsTrastuzumab emtansine·Albumin-Bound Paclitaxel
Fudan University
Observational
250
Shanghai
2025-09-01
Recruiting
Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
NCT07134660Postoperative Pain, Acute, Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
210
Shanghai
2025-09-01
Not yet open
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
NCT07117175Immunology, Hematologic Malignancies, CAR-NK
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
18
Shanghai
2025-09-01
Recruiting
(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
NCT07151521ANCA-associated Vasculitis
Ruijin Hospital
Observational
30
Shanghai
2025-09-01
Not yet open
De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial
NCT07153757Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Fudan University
Phase 3
2,934
Shanghai
2025-09-01
Not yet open
Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents
NCT07120737Myopia, High Myopia
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
224
Shanghai
2025-09-01
Not yet open
A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer
NCT07123441Colorectal Cancer
Sanjun Cai
Phase 2
300
Shanghai
2025-09-01
Not yet open
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
NCT07156656Type A Aortic Dissection, Organ Failure, Multiple
Shanghai Zhongshan Hospital
Phase 4
236
Hefei, Fuzhou, Guangzhou, Shenzhen, Xi'an, Shanghai
2025-09-01
Not yet open
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
NCT07153744Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
DrugAspirin
Shanghai Hutchison Pharmaceuticals Limited
Phase 4
9,588
Shanghai
2025-09-01
Not yet open
RSPO3/SDC-1 Pathway Dysfunction in Alveolar Repair After ARDS in Older Adults
NCT07129330Acute Respiratory Distress Syndrome (ARDS), Age-related Impaired Alveolar Epithelial Repair
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2025-09-01
Recruiting
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826Clostridium Difficile Infection Recurrence, Ulcerative Colitis (UC), Crohn Disease (CD), Irritable Bowel Syndrome (IBS)
Chen QiYi
Observational
4,000
Shanghai
2025-09-01
Not yet open
Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer
NCT07169916Biliary Tract Cancer (BTC)
Fudan University
Not applicable
210
Shanghai
2025-09-01
Recruiting
Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy
NCT07204132Bladder Cancer
Changhai Hospital
Not applicable
180
Shanghai
2025-09-01
By invitation
Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer Surgery
NCT07798466Breast Cancer, Breast Reconstruction, Radiotherapy
Fudan University
Observational
128
Shanghai
2025-09-01
Not yet open
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
NCT07087847Acute Leukemia, Acute Leukemia Refractory, Acute Myeloid Leukemia (AML), ALL (Acute B-Lymphoblastic Leukemia)
DrugTCR
Ruijin Hospital
Not applicable
18
Shanghai
2025-09-01
Recruiting
Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
NCT07168122Healthy Adult, Cushing Syndrome, Adrenal Insufficiency
Shanghai 6th People's Hospital
Observational
220
Shanghai
2025-09-01
Recruiting
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
NCT07135856Lung Cancer, Neoadjuvant Therapy
Shanghai Chest Hospital
Observational
400
Shanghai
2025-09-01
Recruiting
The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
NCT07527884Spinal Metastases, Spinal Tumor, Radiotherapy, Separation Surgery
Wei Xu
Not applicable
130
Shanghai
2025-09-01
Recruiting
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease
NCT07165470Colonoscopy: Bowel Preparation, IBD - Inflammatory Bowel Disease
Changhai Hospital
Not applicable
500
Shanghai
2025-09-01
Not yet open
A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection
NCT07142200Bladder (Urothelial, Transitional Cell) Cancer
DrugDisitamab Vedotin
RenJi Hospital
Phase 2
45
Shanghai
2025-09-01
Not yet open
Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction
NCT07139912Aortic Arch Disease
Shanghai MicroPort Endovascular MedTech๏ผˆGroup๏ผ‰Co., Ltd
Not applicable
96
Shanghai
2025-09
Not yet open
Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT07172126Metastatic Castration-resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
291
Chongqing, Zhuhai, Shanghai
2025-09
Recruiting
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
NCT07174843Idiopathic Inflammatory Myopathies(IIM), Immune Thrombocytopenia(ITP), Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
20
Shanghai
2025-09
Not yet open
Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules
NCT05871437Breast Cancer
DrugHuaier
Fudan University
Phase 4
232
Shanghai
2025-09
Not yet open
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
NCT07150208Breast Cancer With Brain Metastasis, HER2-low Expressing Breast Cancer
Fudan University
Phase 2
140
Shanghai
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Shanghai
2025-09
Recruiting
Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
NCT07106034Advanced Colorectal Cancer
DrugsFolfiri·Folfox·Tislelizumab·Bevacizumab
Shanghai Pudong Hospital
Phase 2
32
Shanghai
2025-08-31
Rows per page Showing 1101–1200 of 3827
Previous 10 11 12 13 14 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=12

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.